Aflac Incorporated (NYSE:AFL) Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC reduced its stake in Aflac Incorporated (NYSE:AFLGet Rating) by 3.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 13,848 shares of the financial services provider’s stock after selling 544 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Aflac were worth $892,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Massmutual Trust Co. FSB ADV lifted its holdings in shares of Aflac by 120.2% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 403 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Rather & Kittrell Inc. purchased a new stake in Aflac during the 4th quarter worth approximately $27,000. Independence Bank of Kentucky increased its stake in Aflac by 96.8% during the 1st quarter. Independence Bank of Kentucky now owns 492 shares of the financial services provider’s stock worth $32,000 after buying an additional 242 shares during the period. Rise Advisors LLC increased its stake in Aflac by 74.7% during the 1st quarter. Rise Advisors LLC now owns 573 shares of the financial services provider’s stock worth $37,000 after buying an additional 245 shares during the period. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in Aflac during the 1st quarter worth approximately $37,000. 66.32% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Down 0.1 %

Shares of NYSE:AFL opened at $59.50 on Friday. The stock has a market cap of $37.60 billion, a P/E ratio of 8.97, a P/E/G ratio of 2.22 and a beta of 0.91. The firm has a fifty day moving average price of $59.30 and a 200 day moving average price of $59.55. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.07 and a quick ratio of 0.07. Aflac Incorporated has a 1-year low of $51.28 and a 1-year high of $67.20.

Aflac (NYSE:AFLGet Rating) last issued its quarterly earnings results on Monday, August 1st. The financial services provider reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.27. The firm had revenue of $5.40 billion during the quarter, compared to analysts’ expectations of $4.79 billion. Aflac had a net margin of 20.37% and a return on equity of 12.40%. Aflac’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.59 EPS. Sell-side analysts predict that Aflac Incorporated will post 5.37 EPS for the current year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 1st. Investors of record on Wednesday, August 24th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date was Tuesday, August 23rd. Aflac’s dividend payout ratio is currently 24.13%.

Insider Buying and Selling

In other news, Director Barbara K. Rimer sold 11,026 shares of the firm’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $58.49, for a total value of $644,910.74. Following the completion of the sale, the director now owns 33,413 shares in the company, valued at approximately $1,954,326.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Barbara K. Rimer sold 11,026 shares of the firm’s stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $58.49, for a total value of $644,910.74. Following the completion of the sale, the director now owns 33,413 shares in the company, valued at approximately $1,954,326.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Teresa L. White sold 10,000 shares of the firm’s stock in a transaction on Friday, August 5th. The stock was sold at an average price of $59.24, for a total transaction of $592,400.00. Following the completion of the sale, the insider now owns 134,256 shares of the company’s stock, valued at approximately $7,953,325.44. The disclosure for this sale can be found here. Insiders sold a total of 38,272 shares of company stock worth $2,338,959 in the last 90 days. Company insiders own 1.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Citigroup assumed coverage on shares of Aflac in a research note on Monday, May 23rd. They set a “neutral” rating and a $60.00 target price on the stock. Piper Sandler dropped their price objective on shares of Aflac from $68.00 to $66.00 and set an “overweight” rating on the stock in a research report on Friday, July 8th. JPMorgan Chase & Co. increased their price objective on shares of Aflac from $61.00 to $62.00 in a research report on Monday, July 11th. Evercore ISI dropped their price objective on shares of Aflac from $60.00 to $59.00 and set an “in-line” rating on the stock in a research report on Wednesday, July 6th. Finally, Morgan Stanley increased their price objective on shares of Aflac from $66.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, August 17th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $62.17.

About Aflac

(Get Rating)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.